Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP (original) (raw)
- Short Communication
- Published: 20 June 2011
Oncogene volume 31, pages 128–134 (2012)Cite this article
- 2455 Accesses
- 3 Altmetric
- Metrics details
Abstract
YAP (Yes-associated protein) oncogene has been found to form a stable complex with members of the Angiomotin (Amot) family of proteins, which bind WW domains of YAP and sequester the protein in the cytoplasm and junctional complexes. The Amot-mediated retention of YAP in the cytoplasm results in the inhibition of its proliferative function. Using apoptotic ‘read-out’ of YAP in HEK293 cells, we confirmed the molecular mode by which Amot regulates YAP. We showed that a representative member of the Amot family, AmotL1 (Angiomotin-like-1), uses its PPxY motifs to bind WW domains of YAP and inhibit YAP's nuclear translocation and pro-apoptotic function. Recently we also showed that YAP uses its PDZ-binding motif to interact with zona occludens-2 (ZO-2) protein, which promotes YAP's translocation to the nucleus. We also asked if AmotL1, YAP and ZO-2 signal together. We report here that AmotL1 and ZO-2 form a tripartite complex with YAP and regulate its function in HEK293 cells in opposite directions. AmotL1 inhibits pro-apoptotic function of YAP, whereas ZO-2 enhances it. As YAP is a potent oncogene, the identification and characterization of its regulators is important. AmotL1 and ZO-2 are two candidates that could be harnessed to control the oncogenic function of YAP.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
References
- Basu S, Totty NF, Irwin MS, Sudol M, Downward J . (2003). Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol Cell 11: 11–23.
Article CAS Google Scholar - Bratt A, Birot O, Sinha I, Veitonmaki N, Aase K, Ernkvist M et al. (2005). Angiomotin regulates endothelial cell-cell junctions and cell motility. J Biol Chem 280: 34859–34869.
Article CAS Google Scholar - Bratt A, Wilson WJ, Troyanovsky B, Aase K, Kessler R, Van Meir EG et al. (2002). Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains. Gene 298: 69–77.
Article CAS Google Scholar - Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C, Hong W . (2011). Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem 286: 7018–7026.
Article CAS Google Scholar - Ehsanian R, Brown M, Lu H, Yang XP, Pattatheyil A, Yan B et al. (2010). YAP dysregulation by phosphorylation or DeltaNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets. Oncogene 29: 6160–6171.
Article CAS Google Scholar - Matallanas D, Romano D, Yee K, Meissl K, Kucerova L, Piazzolla D et al. (2007). RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol Cell 27: 962–975.
Article CAS Google Scholar - Matsuda T, Cepko CL . (2007). Controlled expression of transgenes introduced by in vivo electroporation. Proc Natl Acad Sci USA 104: 1027–1032.
Article CAS Google Scholar - Nishimura M, Kakizaki M, Ono Y, Morimoto K, Takeuchi M, Inoue Y et al. (2002). JEAP, a novel component of tight junctions in exocrine cells. J Biol Chem 277: 5583–5587.
Article CAS Google Scholar - Oka T, Mazack V, Sudol M . (2008). Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). J Biol Chem 283: 27534–27546.
Article CAS Google Scholar - Oka T, Remue E, Meerschaert K, Vanloo B, Boucherie C, Gfeller D et al. (2010). Functional complexes between YAP2 and ZO-2 are PDZ domain-dependent, and regulate YAP2 nuclear localization and signalling. Biochem J 432: 461–472.
Article CAS Google Scholar - Oka T, Sudol M . (2009). Nuclear localization and pro-apoptotic signaling of YAP2 require intact PDZ-binding motif. Genes Cells 14: 607–615.
Article CAS Google Scholar - Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC et al. (2006). Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci U S A 103: 12405–12410.
Article CAS Google Scholar - Pan D . (2010). The hippo signaling pathway in development and cancer. Dev Cell 19: 491–505.
Article CAS Google Scholar - Pei Z, Bai Y, Schmitt AP . (2010). PIV5M protein interaction with host protein angiomotin-like 1. Virology 397: 155–166.
Article CAS Google Scholar - Sowa ME, Bennett EJ, Gygi SP, Harper JW . (2009). Defining the human deubiquitinating enzyme interaction landscape. Cell 138: 389–403.
Article CAS Google Scholar - Strano S, Munarriz E, Rossi M, Castagnoli L, Shaul Y, Sacchi A et al. (2001). Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J Biol Chem 276: 15164–15173.
Article CAS Google Scholar - Sudol M, Harvey KF . (2010). Modularity in the Hippo signaling pathway. Trends Biochem Sci 35: 627–633.
Article CAS Google Scholar - Sudol M . (2010). Newcomers to the WW domain-mediated network of the Hippo tumor suppressor pathway. Genes Cancer 1: 1115–1118.
Article CAS Google Scholar - Sugihara-Mizuno Y, Adachi M, Kobayashi Y, Hamazaki Y, Nishimura M, Imai T et al. (2007). Molecular characterization of angiomotin/JEAP family proteins: interaction with MUPP1/Patj and their endogenous properties. Genes Cells 12: 473–486.
Article CAS Google Scholar - Troyanovsky B, Levchenko T, Mansson G, Matvijenko O, Holmgren L . (2001). Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol 152: 1247–1254.
Article CAS Google Scholar - Wang W, Huang J, Chen J . (2011). Angiomotin-like Proteins Associate with and Negatively Regulate YAP1. J Biol Chem 286: 4364–4370.
Article CAS Google Scholar - Yuan M, Tomlinson V, Lara R, Holliday D, Chelala C, Hanada T et al. (2008). Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ 15: 1752–1759.
Article CAS Google Scholar - Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei Q et al. (2011). Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 25: 51–63.
Article Google Scholar
Acknowledgements
We thank Dr Makoto Adachi from Kyoto University in Japan for a kind gift of HA-tagged mouse Amot family plasmids and Priya Raghavan for experiments, which confirmed our initial observations. We also acknowledge members of the Sudol laboratory for helpful comments on the manuscript.
This research was supported by PA Breast Cancer Coalition grants (#60707 and #9200903) and by Geisinger Clinic.
Author information
Author notes
- T Oka
Present address: 4Current address: Tokyo Medical and Dental University, Medical Research Institute, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.,
Authors and Affiliations
- Laboratory of Signal Transduction and Proteomic Profiling, Weis Center for Research, Geisinger Clinic, Danville, PA, USA
T Oka & M Sudol - Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA, USA
A P Schmitt - Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA
M Sudol
Authors
- T Oka
You can also search for this author inPubMed Google Scholar - A P Schmitt
You can also search for this author inPubMed Google Scholar - M Sudol
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence toM Sudol.
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Oka, T., Schmitt, A. & Sudol, M. Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP.Oncogene 31, 128–134 (2012). https://doi.org/10.1038/onc.2011.216
- Received: 09 March 2011
- Revised: 19 April 2011
- Accepted: 28 April 2011
- Published: 20 June 2011
- Issue Date: 05 January 2012
- DOI: https://doi.org/10.1038/onc.2011.216